Skip to main content

Table 2 Detailed description of serology and PCR results with regards to different parameters in 110 dogs.

From: A canine leishmaniasis pilot survey in an emerging focus of visceral leishmaniasis: Posadas (Misiones, Argentina)

Ā Ā 

Sero-pos*

Parasite-pos**

Infected***

Origin

Owner (N = 27)

14 (51.8%)

14 (51.8%)

18 (66.7%)

Ā 

Canine shelter (N = 83)

34 (40.9%)

38 (45.8%)

45 (54.2%)

Sex

Male (N = 66)

30 (45.4%)

32 (48.5%)

40 (60.6%)

Ā 

Female (N = 44)

18 (40.9%)

20 (45.4%)

23 (52.3%)

Breed

Defined breed (N = 27)

16 (59.2%)

11 (40.7%)

16 (59.2%)

Ā 

Mongrel (N = 83)

32 (38.5%)

41 (49.4%)

47 (56.6%)

Age Group

Group 1 (N = 23)

12 (52.2%)

12 (52.2%)

15 (65.2%)

Ā 

Group 2 (N = 55)

24 (43.6%)

29 (52.7%)

34 (61.8%)

Ā 

Group 3 (N = 18)

5 (27.8%)

7 (38.9%)

7 (38.9%)

Ā 

Group 4 (N = 14)

7 (50.0%)

4 (28.6%)

7 (50.0%)

Clinical status

Symptomatic (N = 76)

39 (51.3%)

42 (55.3%)

50 (65.8%)

Ā 

Asymptomatic (N = 34)

9 (26.5%)

10 (29.4%)

13 (38.2%)

Total

(N = 110)

48 (43.6%)

52 (47.3%)

63 (57.3%)

  1. *Sero-pos: seropositive by rK39-ICT and/or IFAT. **Parasite-pos: LnPCR positive on PB and/or LN samples. ***Infected: Sero-pos and/or Parasite-pos.